Sunita N. Misra, MD, PhD
Formerly of Clinical Development and Medical Affairs, Neurelis, Inc, San Diego, California
Narrative Review
Alternative Treatment for Agitation in Schizophrenia and Bipolar Disorder
January 30, 2024
While oral and intramuscular formulations of pharmacologic agents continue to be commonly used to treat acute agitation, novel agents with alternative routes of delivery are becoming available.
